Titre : Gonadotrophine chorionique

Gonadotrophine chorionique : Questions médicales fréquentes

Termes MeSH sélectionnés :

Obsessive-Compulsive Disorder
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Gonadotrophine chorionique : Questions médicales les plus fréquentes", "headline": "Gonadotrophine chorionique : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Gonadotrophine chorionique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-18", "dateModified": "2025-03-13", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Gonadotrophine chorionique" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Protéines de la grossesse", "url": "https://questionsmedicales.fr/mesh/D011257", "about": { "@type": "MedicalCondition", "name": "Protéines de la grossesse", "code": { "@type": "MedicalCode", "code": "D011257", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.780" } } }, "about": { "@type": "MedicalCondition", "name": "Gonadotrophine chorionique", "alternateName": "Chorionic Gonadotropin", "code": { "@type": "MedicalCode", "code": "D006063", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Hirokazu Usui", "url": "https://questionsmedicales.fr/author/Hirokazu%20Usui", "affiliation": { "@type": "Organization", "name": "Department of Obstetrics and Gynecology, Reproductive Medicine, Chiba University Graduate School of Medicine, Chiba, Japan." } }, { "@type": "Person", "name": "Asuka Sato", "url": "https://questionsmedicales.fr/author/Asuka%20Sato", "affiliation": { "@type": "Organization", "name": "Department of Obstetrics and Gynecology, Chiba University Hospital, Chiba University, Chiba, Japan." } }, { "@type": "Person", "name": "Eri Katayama", "url": "https://questionsmedicales.fr/author/Eri%20Katayama", "affiliation": { "@type": "Organization", "name": "Department of Obstetrics and Gynecology, Chiba University Hospital, Chiba University, Chiba, Japan." } }, { "@type": "Person", "name": "Natsuko Nakamura", "url": "https://questionsmedicales.fr/author/Natsuko%20Nakamura", "affiliation": { "@type": "Organization", "name": "Department of Obstetrics and Gynecology, Chiba University Hospital, Chiba University, Chiba, Japan." } }, { "@type": "Person", "name": "Kaori Koga", "url": "https://questionsmedicales.fr/author/Kaori%20Koga", "affiliation": { "@type": "Organization", "name": "Department of Obstetrics and Gynecology, Reproductive Medicine, Chiba University Graduate School of Medicine, Chiba, Japan." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "EXISTENTIAL OBSESSIONS: A CASE REPORT OF A POSTPARTUM OBSESSIVE COMPULSIVE DISORDER.", "datePublished": "2022-09-01", "url": "https://questionsmedicales.fr/article/36273385", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": null } }, { "@type": "ScholarlyArticle", "name": "Comparison of Obsessive-Compulsive Disorder and Schizophrenia With Comorbid Obsessive-Compulsive Disorder in Terms of Insight, Metacognitive Beliefs, and Clinical Features.", "datePublished": "2022-10-25", "url": "https://questionsmedicales.fr/article/36315973", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/NMD.0000000000001608" } }, { "@type": "ScholarlyArticle", "name": "Predictors of the 6-year outcome of obsessive-compulsive disorder: Findings from the Netherlands Obsessive-Compulsive Disorder Association study.", "datePublished": "2023-05-14", "url": "https://questionsmedicales.fr/article/37183408", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/00048674231173342" } }, { "@type": "ScholarlyArticle", "name": "Metacognition and the effect of incentive motivation in two compulsive disorders: Gambling disorder and obsessive-compulsive disorder.", "datePublished": "2022-06-29", "url": "https://questionsmedicales.fr/article/35674699", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/pcn.13434" } }, { "@type": "ScholarlyArticle", "name": "Association of Obsessive-Compulsive Disorder and Obsessive-Compulsive Symptoms With Substance Misuse in 2 Longitudinal Cohorts in Sweden.", "datePublished": "2022-06-01", "url": "https://questionsmedicales.fr/article/35666504", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1001/jamanetworkopen.2022.14779" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines de la grossesse", "item": "https://questionsmedicales.fr/mesh/D011257" }, { "@type": "ListItem", "position": 5, "name": "Gonadotrophine chorionique", "item": "https://questionsmedicales.fr/mesh/D006063" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Gonadotrophine chorionique - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Gonadotrophine chorionique", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-15", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Gonadotrophine chorionique", "description": "Comment se diagnostique une grossesse avec la gonadotrophine chorionique ?\nQuels niveaux de gonadotrophine indiquent une grossesse normale ?\nPeut-on utiliser la gonadotrophine chorionique pour diagnostiquer des tumeurs ?\nQuels tests sont utilisés pour mesurer la gonadotrophine chorionique ?\nQuand doit-on mesurer la gonadotrophine chorionique après la conception ?", "url": "https://questionsmedicales.fr/mesh/D006063?mesh_terms=Obsessive-Compulsive+Disorder&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Gonadotrophine chorionique", "description": "Quels symptômes indiquent une grossesse précoce ?\nLa gonadotrophine chorionique cause-t-elle des effets secondaires ?\nQuels signes peuvent indiquer une grossesse extra-utérine ?\nComment la gonadotrophine chorionique affecte-t-elle l'humeur ?\nQuels symptômes peuvent indiquer une hyperstimulation ovarienne ?", "url": "https://questionsmedicales.fr/mesh/D006063?mesh_terms=Obsessive-Compulsive+Disorder&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Gonadotrophine chorionique", "description": "Peut-on prévenir les complications liées à la gonadotrophine chorionique ?\nComment réduire le risque de grossesse extra-utérine ?\nY a-t-il des mesures préventives pour l'hyperstimulation ovarienne ?\nComment le mode de vie influence-t-il la fertilité ?\nLes femmes doivent-elles se faire dépister avant un traitement de fertilité ?", "url": "https://questionsmedicales.fr/mesh/D006063?mesh_terms=Obsessive-Compulsive+Disorder&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Gonadotrophine chorionique", "description": "Comment la gonadotrophine chorionique est-elle utilisée en fertilité ?\nQuels sont les traitements pour les niveaux anormaux de gonadotrophine ?\nLa gonadotrophine chorionique est-elle utilisée pour traiter des tumeurs ?\nQuels médicaments contiennent de la gonadotrophine chorionique ?\nComment la gonadotrophine chorionique est-elle administrée ?", "url": "https://questionsmedicales.fr/mesh/D006063?mesh_terms=Obsessive-Compulsive+Disorder&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Gonadotrophine chorionique", "description": "Quelles sont les complications possibles de la gonadotrophine chorionique ?\nComment l'hyperstimulation ovarienne se manifeste-t-elle ?\nQuels risques sont associés à une grossesse multiple ?\nLa gonadotrophine chorionique peut-elle causer des problèmes de santé mentale ?\nQuels sont les effets à long terme de la gonadotrophine chorionique ?", "url": "https://questionsmedicales.fr/mesh/D006063?mesh_terms=Obsessive-Compulsive+Disorder&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Gonadotrophine chorionique", "description": "Quels facteurs augmentent le risque d'hyperstimulation ovarienne ?\nComment l'âge influence-t-il la fertilité ?\nLes antécédents médicaux influencent-ils la réponse à la gonadotrophine chorionique ?\nQuels comportements de santé peuvent affecter la fertilité ?\nY a-t-il des facteurs environnementaux qui influencent la fertilité ?", "url": "https://questionsmedicales.fr/mesh/D006063?mesh_terms=Obsessive-Compulsive+Disorder&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment se diagnostique une grossesse avec la gonadotrophine chorionique ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un test sanguin ou urinaire détecte la présence de la gonadotrophine chorionique." } }, { "@type": "Question", "name": "Quels niveaux de gonadotrophine indiquent une grossesse normale ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des niveaux de 5 à 426 mUI/ml sont typiques au début de la grossesse." } }, { "@type": "Question", "name": "Peut-on utiliser la gonadotrophine chorionique pour diagnostiquer des tumeurs ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des niveaux élevés peuvent indiquer des tumeurs germinales ou trophoblastiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour mesurer la gonadotrophine chorionique ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les tests immunologiques, comme les tests ELISA, sont couramment utilisés." } }, { "@type": "Question", "name": "Quand doit-on mesurer la gonadotrophine chorionique après la conception ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Elle doit être mesurée environ 1 à 2 semaines après la conception." } }, { "@type": "Question", "name": "Quels symptômes indiquent une grossesse précoce ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des nausées, des seins sensibles et des retards de règles." } }, { "@type": "Question", "name": "La gonadotrophine chorionique cause-t-elle des effets secondaires ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut provoquer des nausées et des vomissements chez certaines femmes." } }, { "@type": "Question", "name": "Quels signes peuvent indiquer une grossesse extra-utérine ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Douleurs abdominales sévères et saignements peuvent signaler une grossesse extra-utérine." } }, { "@type": "Question", "name": "Comment la gonadotrophine chorionique affecte-t-elle l'humeur ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des fluctuations hormonales peuvent entraîner des changements d'humeur chez certaines femmes." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer une hyperstimulation ovarienne ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Ballonnements, douleurs abdominales et prise de poids rapide peuvent survenir." } }, { "@type": "Question", "name": "Peut-on prévenir les complications liées à la gonadotrophine chorionique ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi médical régulier et des tests précoces peuvent aider à prévenir les complications." } }, { "@type": "Question", "name": "Comment réduire le risque de grossesse extra-utérine ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi médical et une gestion des facteurs de risque peuvent réduire ce risque." } }, { "@type": "Question", "name": "Y a-t-il des mesures préventives pour l'hyperstimulation ovarienne ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Une surveillance attentive lors des traitements de fertilité peut prévenir l'hyperstimulation." } }, { "@type": "Question", "name": "Comment le mode de vie influence-t-il la fertilité ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain, y compris une alimentation équilibrée, peut améliorer la fertilité." } }, { "@type": "Question", "name": "Les femmes doivent-elles se faire dépister avant un traitement de fertilité ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un dépistage complet est recommandé pour identifier les problèmes de fertilité." } }, { "@type": "Question", "name": "Comment la gonadotrophine chorionique est-elle utilisée en fertilité ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Elle est administrée pour induire l'ovulation et soutenir la grossesse." } }, { "@type": "Question", "name": "Quels sont les traitements pour les niveaux anormaux de gonadotrophine ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement dépend de la cause sous-jacente, comme des médicaments ou une chirurgie." } }, { "@type": "Question", "name": "La gonadotrophine chorionique est-elle utilisée pour traiter des tumeurs ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut être utilisée dans le traitement de certains types de tumeurs germinales." } }, { "@type": "Question", "name": "Quels médicaments contiennent de la gonadotrophine chorionique ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments comme l'HCG sont utilisés pour la fertilité et le traitement hormonal." } }, { "@type": "Question", "name": "Comment la gonadotrophine chorionique est-elle administrée ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Elle est généralement administrée par injection intramusculaire ou sous-cutanée." } }, { "@type": "Question", "name": "Quelles sont les complications possibles de la gonadotrophine chorionique ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'hyperstimulation ovarienne et les grossesses multiples." } }, { "@type": "Question", "name": "Comment l'hyperstimulation ovarienne se manifeste-t-elle ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Elle se manifeste par des douleurs abdominales, des nausées et un gonflement abdominal." } }, { "@type": "Question", "name": "Quels risques sont associés à une grossesse multiple ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les grossesses multiples augmentent le risque de complications pour la mère et les bébés." } }, { "@type": "Question", "name": "La gonadotrophine chorionique peut-elle causer des problèmes de santé mentale ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Des fluctuations hormonales peuvent affecter l'humeur et provoquer de l'anxiété." } }, { "@type": "Question", "name": "Quels sont les effets à long terme de la gonadotrophine chorionique ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les effets à long terme sont généralement rares, mais un suivi est recommandé." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque d'hyperstimulation ovarienne ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'âge, le poids et des antécédents d'hyperstimulation augmentent ce risque." } }, { "@type": "Question", "name": "Comment l'âge influence-t-il la fertilité ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "L'âge avancé peut réduire la qualité des ovules et augmenter les risques de complications." } }, { "@type": "Question", "name": "Les antécédents médicaux influencent-ils la réponse à la gonadotrophine chorionique ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de troubles hormonaux peuvent affecter la réponse au traitement." } }, { "@type": "Question", "name": "Quels comportements de santé peuvent affecter la fertilité ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Le tabagisme, l'alcool et le stress peuvent nuire à la fertilité et à la réponse hormonale." } }, { "@type": "Question", "name": "Y a-t-il des facteurs environnementaux qui influencent la fertilité ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des toxines environnementales peut affecter la fertilité." } } ] } ] }

Sources (10000 au total)

Comparison of Obsessive-Compulsive Disorder and Schizophrenia With Comorbid Obsessive-Compulsive Disorder in Terms of Insight, Metacognitive Beliefs, and Clinical Features.

The aim was to compare insight levels into obsessive-compulsive symptoms (OCS), and metacognitions of patients with obsessive-compulsive disorder (OCD) and with schizophrenia with comorbid OCD (SZ-OCD...

Predictors of the 6-year outcome of obsessive-compulsive disorder: Findings from the Netherlands Obsessive-Compulsive Disorder Association study.

Obsessive-compulsive disorder is characterized by a chronic course that can vary between patients. The knowledge on the naturalistic long-term outcome of obsessive-compulsive disorder and its predicto... We included 377 individuals with a current diagnosis of obsessive-compulsive disorder, who participated in the Netherlands Obsessive Compulsive Disorder Association study, a multicenter naturalistic c... The overall course of obsessive-compulsive disorder was characterized by two prominent trends: the first reflected an improvement in symptom severity, which was mitigated by the second, worsening tren... The long-term outcome of obsessive-compulsive disorder in naturalistic settings was characterized by an overall improvement in symptom severity, which was gradually halted to the point of increased wo...

Metacognition and the effect of incentive motivation in two compulsive disorders: Gambling disorder and obsessive-compulsive disorder.

Compulsivity is a common phenotype among psychiatric disorders, such as obsessive-compulsive disorder (OCD) and gambling disorder (GD). Deficiencies in metacognition, such as the inability to estimate... We hypothesized GD's overconfidence to be exaggerated during gain prospects, while OCD's underconfidence to be worsened in loss context, which we expected to see represented in ventromedial prefrontal... We showed increased confidence for patients with GD versus patients with OCD, which could partly be explained by sex and IQ. Although our primary analyses did not support the hypothesized interaction ... Patients with OCD and those with GD reside at opposite ends of the confidence spectrum, while no interaction with incentives was found, nor group differences in neuronal processing of confidence....

Association of Obsessive-Compulsive Disorder and Obsessive-Compulsive Symptoms With Substance Misuse in 2 Longitudinal Cohorts in Sweden.

Neurobiological models have postulated shared neural mechanisms between obsessive-compulsive disorder (OCD) and substance use disorders, but results from clinical and epidemiological studies are confl... To investigate whether OCD and obsessive-compulsive symptoms are associated with substance misuse and the extent to which shared genetic and/or environmental factors account for this association.... In this cohort study, individuals in the general population of Sweden born between January 1, 1932, and December 31, 1997 (population cohort), were followed up through Swedish nationwide registers fro... Lifetime International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, diagnosis of OCD in the National Patient Register (population cohort 1), and self-reported ob... Substance misuse was defined as registered substance use-related disorder, criminal conviction, or death (population cohort), and self-reported alcohol and drug dependence symptoms at 18 and 24 years ... The general population cohort included 6 304 188 individuals (48.9% women and 51.1% men; median baseline age, 30.5 [IQR, 15.0-46.4] years), of whom 27 342 had an OCD diagnosis. Obsessive-compulsive di... The findings of this Swedish population-based cohort study challenge the notion that OCD is protective against developing substance misuse. The association of OCD and obsessive-compulsive symptoms wit...

Empirically Defining Treatment Response and Remission in Obsessive-Compulsive Disorder Using the Obsessive-Compulsive Inventory-Revised.

In clinical trials of obsessive-compulsive disorder (OCD), clinical outcomes are generally measured using lengthy clinician-administered interviews. However, in routine clinical practice, many clinici...